SL Science Holding Ltd (SLBT) stock
SLBTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 18, 2026
$0.64−0.08 (-11.73%)
Close on Nov 17, 2026Market cap $356.14MP/E –Yield –
SL Science cash
Cash and short-term investments held at the end of each period.
SL Science's cash was $8.31M at Jun 30, 2026. For fiscal 2025 it was $1.26M, down 69.6% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.26M | -69.6% |
| FY2024 | Dec 31, 2024 | $4.14M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.31M | – |
| Q4 FY2025 | Dec 31, 2025 | $1.26M | – |
| Q2 FY2025 | Jun 30, 2025 | $3.55M | – |
| Q4 FY2024 | Dec 31, 2024 | $4.14M | – |
See a number that looks wrong?